Biocon Bengaluru unit pre-approval inspection by USFDA concludes with zero observations

Biocon on Monday said that pre-approval inspection of the Bengaluru facility of its arm conducted by US health regulator was concluded with zero observations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2G2tpVQ
via IFTTT

0 comments:

Post a Comment